ArticleMissouri medicine
Small Incision Lenticule Extraction SMILE - The Future of Refractive Surgery is Here.
Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 9 citations in OpenAlex.
- Knowledge, attitudes, and practices toward femtosecond laser small incision lenticule extraction surgery and postoperative care among recipients.BMC public health · 2024Article
- Impact of unintended initial dissection of the posterior plane during SMILE surgery on surgery time and visual outcomes.BMC ophthalmology · 2022Article
- Femtosecond-laser-assisted Small Incision Lenticule Extraction to Treat Refractive Error: A Narrative Review.Middle East African journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small Incision Lenticule Extraction (SMILE) is a relatively new one-step refractive procedure that has recently been approved by the FDA for the treatment of myopia. It is anticipated myopic astigmatism will be FDA-approved in 2019. The SMILE procedure is shown to have similar efficacy, safety, predictability, and stability as current surgical options, such as LASIK, but has been gaining popularity due to fewer potential complications, such as dry eye incidence and greater biomechanical stability, and faster recovery time. This article discusses the SMILE procedure, its benefits, risks, uncertainties, and potential future in the world of refractive surgery.
Indexed as
Identifiers
30228689PMC6139791W2997654055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.